Literature DB >> 8871142

Diagnostic vitrectomy and chronic uveitis.

H Verbraeken1.   

Abstract

BACKGROUND: From the introduction of vitrectomy, infectious endophthalmitis was one of the indications for this surgical technique. Vitrectomy was later found to be a valuable method in both diagnostic and therapeutic evaluation of chronic uveitis.
METHODS: Twenty-eight eyes of 25 patients were operated on with purely diagnostic intent. These were patients not responding, or no longer responding, to their cortisone treatment and for whom no etiology had been found previously.
RESULTS: Vitrectomy itself yielded the diagnosis in nine eyes of eight patients. Three had unexpected infectious pathology (one bacterial, one mycotic, one viral), while five had tumoral pathology four with non-Hodgkin lymphoma and one with a metastasis of a malignant melanoma of the skin. In four other patients, typical fundus lesions were seen during the surgery, providing a clue to the etiology: three cases of retinal necrosis and one case of a pseudotumoral mass suggestive of Toxocara canis. Serologic tests confirmed three cases of herpes simplex infection and one of Toxocara canis. Apart from the fact that a diagnosis could be made in half of the patients, the diagnostic vitrectomy also had a favorable effect upon vision in half the cases.
CONCLUSION: In cases of chronic uveitis where no etiology has been found, vitrectomy is able to provide a diagnosis in about one-third of eyes directly. During surgery a typical appearance of the fundus may reveal a supplementary diagnosis, resulting in an overall diagnosis in about half of the cases. Moreover, half of the patients will have improved vision after surgery.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8871142     DOI: 10.1007/bf02343040

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  18 in total

1.  The uses and limitations of intraocular biopsy.

Authors:  W S Foulds
Journal:  Eye (Lond)       Date:  1992       Impact factor: 3.775

2.  Pars plana vitrectomy in the treatment of chronic uveitis.

Authors:  K Heimann; L Schmanke; R Brunner; B Amerian
Journal:  Dev Ophthalmol       Date:  1992

3.  [Pars plana vitrectomy in chronic uveitis].

Authors:  R Klöti
Journal:  Klin Monbl Augenheilkd       Date:  1988-05       Impact factor: 0.700

4.  Immunocytochemical staining of vitreous cells. Indications, techniques, and results.

Authors:  J L Davis; D Solomon; R B Nussenblatt; A G Palestine; C C Chan
Journal:  Ophthalmology       Date:  1992-02       Impact factor: 12.079

5.  Ocular metastases from systemic melanoma.

Authors:  D H Char; A Schwartz; T R Miller; J S Abele
Journal:  Am J Ophthalmol       Date:  1980-11       Impact factor: 5.258

6.  The clinical spectrum of ocular lymphoma.

Authors:  K Peterson; K B Gordon; M H Heinemann; L M DeAngelis
Journal:  Cancer       Date:  1993-08-01       Impact factor: 6.860

7.  Bacteriological study of 92 cases of proven infectious endophthalmitis treated with pars plana vitrectomy.

Authors:  H Verbraeken; M Rysselaere
Journal:  Ophthalmologica       Date:  1991       Impact factor: 3.250

8.  Intracapsular and extracapsular pseudophakic endophthalmitis: a comparison.

Authors:  H E Verbraeken
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

9.  Management of infectious endophthalmitis.

Authors:  R K Forster; R L Abbott; H Gelender
Journal:  Ophthalmology       Date:  1980-04       Impact factor: 12.079

Review 10.  Endophthalmitis after lens extraction.

Authors:  H E Verbraeken
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

View more
  10 in total

1.  [Practical advice for recovery and successful processing of anterior chamber puncture and vitrectomy samples].

Authors:  S Thurau
Journal:  Ophthalmologe       Date:  2003-10       Impact factor: 1.059

2.  25-gauge transconjunctival diagnostic vitrectomy in suspected cases of intraocular lymphoma: a case series and review of the literature.

Authors:  Mozhgan Rezaei Kanavi; Masoud Soheilian; Sayed Bagher Hosseini; Amir A Azari
Journal:  Int J Ophthalmol       Date:  2014-06-18       Impact factor: 1.779

3.  Diagnostic yield of vitreous biopsy in presumed sarcoidosis-related posterior segment inflammation.

Authors:  Adrienne W Scott; Prithvi Mruthyunjaya; Rex M McCallum; Glenn J Jaffe
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-03-21       Impact factor: 3.117

Review 4.  Diagnostic vitrectomy for infectious uveitis.

Authors:  Abdallah Jeroudi; Steven Yeh
Journal:  Int Ophthalmol Clin       Date:  2014

5.  [Unusual masquerade of an ocular carcinoma metastasis].

Authors:  M I Wunderlich; E J Nissen; M Schargus; H B Dick; M Pohl; S E Coupland; V Kakkassery
Journal:  Ophthalmologe       Date:  2016-08       Impact factor: 1.059

6.  Demonstration of Bartonella grahamii DNA in ocular fluids of a patient with neuroretinitis.

Authors:  F T Kerkhoff; A M Bergmans; A van Der Zee; A Rothova
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

7.  A case of cutaneous melanoma metastatic to the vitreous cavity: possible pathomechanism and review of the literature.

Authors:  Gesine B Jaissle; Peter Szurman; Jens Martin Rohrbach; Faik Gelisken; Karl Ulrich Bartz-Schmidt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-11-22       Impact factor: 3.535

8.  Biopsy pathology in uveitis.

Authors:  Jyotirmay Biswas; Radha Annamalai; Vaijayanthi Krishnaraj
Journal:  Middle East Afr J Ophthalmol       Date:  2011-10

Review 9.  Uveitis in the Aging Eye: Incidence, Patterns, and Differential Diagnosis.

Authors:  Marwan R Abdulaal; Bachir H Abiad; Rola N Hamam
Journal:  J Ophthalmol       Date:  2015-05-18       Impact factor: 1.909

10.  Bilateral hypopyon in syphilitic uveitis.

Authors:  Monica P Gonzalez Collazo; Nicole P Rebollo Rodriguez; Marely Santiago-Vazquez; Susanne M Crespo-Ramos; Maria J Marcos-Martinez; Víctor M Villegas; Armando L Oliver
Journal:  Am J Ophthalmol Case Rep       Date:  2020-12-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.